Management & Directors

Tom Lynch, a Partner, Senior Managing Director, and Head of the Boston office of SierraConstellation Partners, brings with him over two decades of capital market experience with a deep focus in restructuring, workouts, recapitalizations, M&A, secondary market transactions, as well as strategic planning and execution.

Prior to joining SCP, Tom was the co-founder and Managing Partner of Woods Hole Capital. Tom was responsible for the executive management and strategic direction of the firm. Tom focused on all aspects of the firm including risk management, portfolio management, operations and the executive leadership of the firm.

Prior to founding Woods Hole Capital, Tom was the Chairman and Chief Executive Officer of Frederick’s of Hollywood Group (a publicly traded company). In this capacity, Tom led an out of court financial and operational restructuring which culminated in a sale to Phil Falcone’s HRG Group in 2014. Prior to joining Frederick’s, Tom was the CEO of Mellon HBV later renamed Fursa Alternative Strategies. HBV was a risk arbitrage fund that had moved toward event driven less liquid positions.

Tom has a lengthy and distinguished career in the asset management business. As a Managing Director of Mellon Institutional Asset Management, Tom was a member of the Senior Management Committee, and had direct executive responsibility for a 38 billion AUM business. While at Mellon, Tom founded and launched Mellon’s first Alternative Asset Management distribution group.

Tom has held executive positions with UBS Global Asset Management and the Dreyfus Corporation.

Tom is a graduate of St. Anselm College.

Timothy Bossidy has served as Interim Chief Operating Officer since March 2020. Mr. Bossidy is currently a Senior Director at SierraConstellation Partners where he has developed their cannabis practice and served in a number of interim management roles in cannabis and in retail. Prior to joining SierraConstellation Partners, Mr. Bossidy served as an investment banker at Goldman Sachs. Prior to joining Goldman Sachs, Mr. Bossidy served as a fixed income analyst at The Travelers Companies. Mr. Bossidy received a B.A. in Economics and English from the University of Notre Dame and an MBA from Kellogg School of Management at Northwestern University.

Zeeshan Hyder brings nearly a decade of experience analyzing and evaluating investment opportunities for large institutions. He was formerly an investment banker at Citigroup where he advised on M&A transactions across the mining, healthcare and consumer industries. Mr. Hyder was also an investment analyst at The Eli and Edythe Broad Foundation's $2 billion investment fund. Most recently Mr. Hyder was a vice president at First Beverage Ventures, a private equity firm focused on emerging food and beverage brands.

Mike Lane leads the development of digital products that differentiate and extend the MedMen customer experience both online and in-store. He brings more than 20 years of experience in product development and design at major brands like Live Nation, Ticketmaster, FOX Broadcasting, Adobe, and Accenture. Prior to joining MedMen, Mr. Lane was Vice President of Product at global technology innovator Grindr, the world's largest location-based social network connecting the LGBTQ community.

Dan Edwards oversees MedMen’s legal department and ensures operations adhere strictly to applicable laws and regulations. Mr. Edwards brings extensive experience in corporate law, mergers and acquisitions, intellectual property, commercial real estate, cannabis law and compliance, and he has successfully structured and closed over $500 million in cannabis-related transactions. Prior to joining MedMen, Mr. Edwards worked at San Diego business law firm Potente APLC where he developed and managed the firm's first cannabis division.

Felix Popescu oversees MedMen’s strategic planning including interfacing cross-functionally with key stakeholders across the organization to implement strategic initiatives with Human Resources, Insurance, Corporate Optimization, Licensing, and Manufacturing/Distribution among others. He operates with an acute focus on defining MedMen’s strategy and resource allocation to maximize operating leverage and ROI. Mr. Popescu brings nearly ten years of experience advising and executing on mergers and acquisitions. Formerly, he was an investment banker at Lazard and Jefferies. Mr. Popescu also acquired a deep understanding of healthcare services from his time at ProCure, a leader in the radiation oncology space, and most recently at DaVita, one of the largest kidney care providers in the U.S.

Roz Lipsey brings over 25 years of operational experience, focusing on business start-up, scaling and strategy.

After starting her career in the Foreign Service as an Agricultural Economist for foreign cotton/textile markets, Ms. Lipsey was Director of Business Development for a vertically-integrated cotton company, Volkart/Anderson Clayton, with multiple country holdings in farming finance, ginning, cottonseed oil processing, and commodities trading.

Afterwards, Ms. Lipsey joined a family investment office, Jokake Companies, where she built and scaled companies in the agricultural, construction and building materials industries to successful M&A outcomes. In late 2014, she entered the cannabis space, serving as President of a vertically-integrated cannabis operation in Arizona, scaling its cultivation, manufacturing, wholesale and retail businesses.

Ms. Lipsey is a founder of the Advancing Women in Construction Mentorship Program at Arizona State University and has been a member of the Young President’s Organization (YPO) since 2008.